During the last session, Aeglea BioTherapeutics Inc. (NASDAQ:AGLE)’s traded shares were 0.41 million, with the beta value of the company hitting 1.62. At the end
In the last trading session, 0.2 million shares of the Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) were traded, and its beta was 1.62. Most recently the company’s
In last trading session, Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) saw 1.0 million shares changing hands with its beta currently measuring 1.74. Company’s recent per share price
During the last session, Aeglea BioTherapeutics Inc. (NASDAQ:AGLE)’s traded shares were 0.62 million, with the beta value of the company hitting 1.74. At the end